Revenue

The demo automation leader launched a new partner network, promising to connect disparate sales and marketing tools into a single, cohesive revenue engine.

Oculis is advancing a neuroprotective drug for optic neuropathies and a first-of-its-kind eye drop for diabetic macular edema, aiming at $10B+ markets.

After a major win at CES 2026, a South Korean edtech firm is set to bring its revolutionary 'Visual LLM' learning platform to the US K-12 market.

Pharma giant Bayer partners with biotech innovator Soufflé to develop a groundbreaking siRNA therapy, aiming to deliver genetic medicine directly to the heart.

The UK retail giant is ditching manual spreadsheets for an AI-driven platform to standardize labor and enhance customer experience across 240+ stores.

A new clinical benchmark published in a Nature journal reveals a Chinese AI is the safest and most effective, challenging Silicon Valley's dominance.

At CES 2026, BLUETTI moves beyond portable power, unveiling smart home batteries, a sodium-ion first, and a vision for a decentralized energy grid.

At CES 2026, RobotEra's L7 humanoid and 'Hexa-Core' lineup showcase China's growing dominance in the global robotics race. Here's a deep dive.

At CES 2026, LumiMind's BCI tech promises to guide you to sleep and power thought-controlled games, raising major scientific and ethical questions.

Azafaros presents its promising drug, nizubaglustat, for untreatable rare neurological disorders, backed by major funding and late-stage clinical trials.

Beyond the hype, X-Humanoid's robots are running marathons and working on production lines, signaling a major shift from lab demos to real-world deployment.

Ahrefs expands its Brand Radar to track YouTube, TikTok, and Reddit, aiming to give marketers a unified view of brand discovery in the age of AI.

At CES 2026, new optical engines from Appotronics promise to make AR glasses as light as normal eyewear, sparking a race toward an affordable, all-day wearable future.

Biotech leader Arrowhead Pharmaceuticals prices upsized offerings, signaling strong investor confidence and fueling its next wave of RNAi therapies.

Nanyang Polytechnic's new AI Nexus Lab, backed by AWS, pairs students with small businesses to solve real-world problems and close Singapore's AI gap.

The pharmaceutical giant is expanding its partnership with Veeva, adopting a next-gen CRM with agentic AI to transform its global commercial execution.

South Korean gim specialist Daingt is leveraging proprietary data and a 20-year legacy to innovate its seaweed, aiming to dominate the booming global market.

With its CEO stepping down, Lifeist Wellness tasks its CFO with a dual role, signaling a push for stability as it navigates a tough market.

Interim results from the SPARTAN study reveal a novel lateral-oblique SI joint fusion system offers significant pain reduction and improved function.

Rebranded and recapitalized, Future Mineral Resources is raising $4.5M to advance its gold, uranium, and nickel projects across three continents.